BFA
AMGN icon

Bill Few Associates’s Amgen AMGN Stock Holding History

Bill Few Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$789K Sell
2,180
-58
-3% -$19.9K 0.17% 98
2026
Q1 		$788K Buy
2,238
+385
+21% +$137K 0.19% 97
2025
Q4 		$606K Buy
1,853
+176
+10% +$55.8K 0.15% 104
2025
Q3 		$473K Hold
1,677
– – 0.12% 115
2025
Q2 		$468K Buy
1,677
+28
+2% +$7.93K 0.13% 113
2025
Q1 		$514K Sell
1,649
-9
-0.5% -$2.66K 0.18% 96
2024
Q4 		$432K Buy
1,658
+12
+0.7% +$3.56K 0.15% 103
2024
Q3 		$530K Hold
1,646
– – 0.19% 97
2024
Q2 		$514K Buy
1,646
+7
+0.4% +$2.06K 0.2% 92
2024
Q1 		$466K Buy
1,639
+6
+0.4% +$1.76K 0.19% 94
2023
Q4 		$470K Hold
1,633
– – 0.21% 86
2023
Q3 		$439K Hold
1,633
– – 0.23% 80
2023
Q2 		$363K Hold
1,633
– – 0.19% 90
2023
Q1 		$395K Hold
1,633
– – 0.22% 85
2022
Q4 		$429K Hold
1,633
– – 0.25% 76
2022
Q3 		$368K Buy
1,633
+50
+3% +$12.1K 0.25% 76
2022
Q2 		$385K Sell
1,583
-40
-2% -$9.8K 0.25% 72
2022
Q1 		$392K Sell
1,623
-1
-0.1% -$230 0.21% 84
2021
Q4 		$365K Buy
+1,624
New +$343K 0.19% 88

Other funds holding AMGN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Bill Few Associates's AMGN Position: Q2 2026 in Review

Bill Few Associates reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $19.9K and leaving 2,180 shares worth $789K. The position accounts for 0.17% of the portfolio, ranked #98.

Bill Few Associates first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bill Few Associates held 2,180 shares of Amgen worth $789K as of Q2 2026.
  • Bill Few Associates sold 58 Amgen shares in Q2 2026, an estimated $19.9K.
  • Amgen made up 0.17% of Bill Few Associates's portfolio in Q2 2026, its #98 holding.
  • Bill Few Associates first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.